nuere, at least its not a poster presentation which implies something substantive. I think they started enrolling only a year ago. I would love to know how to "weight" their contention that the ET study (100%response rate) provides true proof of concept. Are ET and MF similar enough regarding the progenitor cells involve to make such a statement. If so the results could be impressive. This is a single agent trial and my suspicion is the there will be encouraging results but some statement about the need to find more effective combinations etc. bp
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.